Target intelligence / Profile preview

Novel transcript, antisense to TBX4 (ENSG00000303786)

Target: ENSG00000303786
Molecular classification: lncRNA

Overview

ENSG00000303786 is annotated as a novel long non-coding RNA (lncRNA) gene located antisense to the TBX4 gene. As of current knowledge, there is no experimental or clinical evidence linking this transcript to a functional role in biology, disease, or as a therapeutic target. It is primarily a product of large-scale genome annotation projects and does not encode a protein, nor does it have established relevance as a regulator or biomarker[3].

Biological functions

Unknown (No documented molecular or cellular function)

Disease associations

None established

Beyond the preview

Go deeper on Novel transcript, antisense to TBX4 (ENSG00000303786).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript, antisense to TBX4 (ENSG00000303786).

Explore the full profile